Gender Bias in Medicine: “How Women Continue to Get the Shaft When It Comes to Testosterone Therapies”

Angela Marie Derosa

doi:10.1089/andro.2021.0005

Abstract

Gender Bias in Medicine: “How Women Continue to Get the Shaft When It Comes to Testosterone Therapies”

Highlights

Women experience the loss of sex drive at the same rate as men and have more prevalent symptoms due to the loss of the reproductive hormones estradiol and testosterone.[1,2,3,4]
Testosterone replacement therapies and medications for men remain a billion-dollar industry, there is a paucity of options for women
This research is often affiliated with medical organizations, societies, and pharmaceutical companies that seem to have an interest in preserving the status quo of limited and clinically obsolete Food and Drug Administration (FDA)-approved treatment options for women

Summary

Introduction

Women experience the loss of sex drive at the same rate as men and have more prevalent symptoms due to the loss of the reproductive hormones estradiol and testosterone.[1,2,3,4] Yet, testosterone replacement therapies and medications for men remain a billion-dollar industry, there is a paucity of options for women. These compounded hormone products, are often a regular target of some in medicine who cite research while attacking them.[11] This research is often affiliated with medical organizations, societies, and pharmaceutical companies that seem to have an interest in preserving the status quo of limited and clinically obsolete FDA-approved treatment options for women.

Results

Conclusion